Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tejshri Telkhade"'
Autor:
Rahul Krishnatry, Priyamvada Maitre, Anuj Kumar, Tejshri Telkhade, Ganesh Bakshi, Gagan Prakash, Mahendra Pal, Amit Joshi, Santosh Menon, Vedang Murthy
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11305-11314 (2023)
Abstract Background To assess urinary symptoms and urine cytology as screening tools for cystoscopic detection of local recurrence after bladder‐preserving trimodality treatment (TMT). Methods Patients with muscle‐invasive bladder cancer receivin
Externí odkaz:
https://doaj.org/article/a0a7219c47374dd89e2bb289c2183815
Autor:
Vedang Murthy, Indranil Mallick, Abhilash Gavarraju, Shwetabh Sinha, Rahul Krishnatry, Tejshri Telkhade, Arunsingh Moses, Sadhna Kannan, Gagan Prakash, Mahendra Pal, Santosh Menon, Palak Popat, Venkatesh Rangarajan, Archi Agarwal, Sheetal Kulkarni, Ganesh Bakshi
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionThere has been an interest in studying the efficacy of extreme hypofractionation in low and intermediate risk prostate cancer utilising the low alpha/beta ratio of prostate. Its role in high-risk and node-positive prostate cancer, however
Externí odkaz:
https://doaj.org/article/9a8d030706724801a5c943b89f3c35a3
Autor:
Robert Foerster, Daniel Rudolf Zwahlen, Andre Buchali, Hongjian Tang, Christina Schroeder, Paul Windisch, Erwin Vu, Sati Akbaba, Tilman Bostel, Tanja Sprave, Constantinos Zamboglou, Thomas Zilli, Jean-Jacques Stelmes, Tejshri Telkhade, Vedang Murthy
Publikováno v:
Cancers, Vol 13, Iss 4, p 759 (2021)
Background: Radiotherapy (RT) is an established, potentially curative treatment option for all risk constellations of localized prostate cancer (PCA). Androgen deprivation therapy (ADT) and dose-escalated RT can further improve outcome in high-risk (
Externí odkaz:
https://doaj.org/article/bef53024e5f84764992806a9c92ec657
Autor:
Kumar Prabhash, Santosh Menon, Gagan Prakash, Mahendra Pal, Ganesh Bakshi, Rahul Krishnatry, Vanita Noronha, Amit Joshi, Vedang Murthy, Asawari Patil, Tejshri Telkhade, P. Khurud
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 34(3)
AIMS Due to the lack of high-quality evidence and consensus on adjuvant treatment for locoregionally advanced penile cancer, we reviewed the outcomes of pN3 patients to determine the suitable adjuvant treatment options. PATIENTS AND METHODS All conse
Autor:
Vedang Murthy, Robert Foerster, Andre Buchali, Tanja Sprave, Tejshri Telkhade, Thomas Zilli, Jean-Jacques Stelmes, Daniel R. Zwahlen, Sati Akbaba, Paul Windisch, Constantinos Zamboglou, Erwin Vu, Hongjian Tang, Christina Schroeder, Tilman Bostel
Publikováno v:
Cancers, Vol 13, Iss 759, p 759 (2021)
Cancers
Cancers
Simple Summary Stereotactic body radiotherapy, i.e., high-precision radiotherapy delivering high doses within a few treatment sessions, is a very convenient treatment option, which has been shown to be effective and well tolerated in prostate cancer
Autor:
J.M. Mathew, Rahul Krishnatry, Reena Phurailatpam, D. Chourasiya, Vedang Murthy, Tejshri Telkhade, Gitanjali Panigrahi, Smruti Mokal, T.S. Kanala
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 33(3)
Aims The safety and efficacy of stereotactic body radiotherapy (SBRT) in localised prostate cancer are now established through phase III randomised trials. Its utility in node-positive prostate cancer is restricted due to a lack of controlled studies
Autor:
Sadhna Kannan, Ganesh Bakshi, Venkatesh Rangarajan, Shwetabh Sinha, Palak Popat, Tejshri Telkhade, Abhilash Gavarraju, Gagan Prakash, Arunsingh Moses, Sheetal V. Kulkarni, Indranil Mallick, Rahul Krishnatry, Santosh Menon, Archi Agarwal, Vedang Murthy, Mahendra Pal
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 2 (2020)
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionThere has been an interest in studying the efficacy of extreme hypofractionation in low and intermediate risk prostate cancer utilising the low alpha/beta ratio of prostate. Its role in high-risk and node-positive prostate cancer, however
Autor:
Tejshri Telkhade, Ashwini Budrukkar, Ritu Raj Upreti, Rajendra A Badwe, Tabassum Wadasadawala, Rakesh Jalali, Rajiv Sarin, Sudeep Gupta, Tanuja Shet
Publikováno v:
Brachytherapy. 19(3)
Purpose The purpose of this study is to evaluate long-term clinical outcomes of women treated with accelerated partial breast irradiation (APBI) using multicatheter interstitial brachytherapy (MIB-APBI) with risk groups defined by Groupe Europeen de